- CA$8.02m
- CA$71.32m
- CA$71.07m
- 51
- 91
- 34
- 60
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 2.25 | ||
| Price to Sales | 0.11 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -49.1% | ||
| Return on Equity | n/a | ||
| Operating Margin | -19.34% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 31.77 | 52.05 | 62.29 | 63.23 | 71.07 | 75.8 | 86.6 | 56.5% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.
Directors
- Nitin Kaushal CHM (56)
- John Arbuthnot CEO (30)
- James Lawson CFO (69)
- John Arbuthnot DRC (66)
- Hugh Aird IND (67)
- Joanne Duhoux-Defehr IND (47)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 16th, 2001
- Public Since
- March 31st, 2004
- No. of Employees
- 200
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 229,061,645
- Address
- Osborne Village, WINNIPEG, R3L 2V9
- Web
- https://www.delta9.ca/
- Phone
- +1 2049975328
- Auditors
- Baker Tilly HMA LLP
Upcoming Events for DN
Delta 9 Cannabis Inc Annual Shareholders Meeting
Q2 2024 Delta 9 Cannabis Inc Earnings Release
Similar to DN
Aurora Cannabis
Toronto Stock Exchange
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
Charlotte's Web Holdings
Toronto Stock Exchange
FAQ
What is the Delta 9 Cannabis share price?
As of Today at 19:06 UTC, shares in Delta 9 Cannabis are trading at CA$0.04. This share price information is delayed by 15 minutes.
How has the Delta 9 Cannabis share price performed this year?
Shares in Delta 9 Cannabis last closed at CA$0.04 and the price had moved by -50% over the past 365 days. In terms of relative price strength the Delta 9 Cannabis share price has underperformed the Toronto Stock Exchange 300 Composite Index by -53.01% over the past year.
What are the analyst and broker recommendations for Delta 9 Cannabis?
The overall consensus recommendation for Delta 9 Cannabis is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Delta 9 Cannabis dividend yield?
Delta 9 Cannabis does not currently pay a dividend.
Does Delta 9 Cannabis pay a dividend?
Delta 9 Cannabis does not currently pay a dividend.
When does Delta 9 Cannabis next pay dividends?
Delta 9 Cannabis does not currently pay a dividend.
How do I buy Delta 9 Cannabis shares?
To buy shares in Delta 9 Cannabis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Delta 9 Cannabis?
As of the previous close price of CA$0.04, shares in Delta 9 Cannabis had a market capitalisation of CA$8.02m.
Where are Delta 9 Cannabis shares listed?
Here are the trading details for Delta 9 Cannabis:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: DN
What kind of share is Delta 9 Cannabis?
Based on an overall assessment of its quality, value and momentum Delta 9 Cannabis is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Delta 9 Cannabis share price forecast for 2024?
The analyst consensus target price for shares in Delta 9 Cannabis is CA$0.06. That is 71.43% above the last closing price of CA$0.04.
Analysts covering Delta 9 Cannabis currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
What is the trend in the Delta 9 Cannabis share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Delta 9 Cannabis. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -21.61%.
As of the last closing price of CA$0.04, shares in Delta 9 Cannabis were trading -9.18% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Delta 9 Cannabis PE Ratio?
The Delta 9 Cannabis PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Delta 9 Cannabis?
Delta 9 Cannabis' management team is headed by:
- Nitin Kaushal - CHM
- John Arbuthnot - CEO
- James Lawson - CFO
- John Arbuthnot - DRC
- Hugh Aird - IND
- Joanne Duhoux-Defehr - IND